Push Admin

Britain looking into AstraZeneca-Alexion deal for competition concerns

Article (news)

Reuters

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2021/reuters/05/26/20210525-alexion-pharms-m-a-astrazeneca-britain.jpg"/><figcaption>The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. <em>Rachel Wisniewski, Reuters/File Photo</em></figcaption></figure></div><p>Britain&#x27;s competition regulator said on Tuesday it was probing if AstraZeneca&#x27;s $39 billion takeover of US drugmaker Alexion could reduce competition for products and services in the country or elsewhere.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/video/business/05/26/21/govt-urged-allow-use-of-astrazeneca-jabs-as-first-dose-for-economic-frontliners">Gov’t urged: Allow use of AstraZeneca jabs as first dose for economic frontliners</a></li>	<li><a href="https://news.abs-cbn.com/news/05/08/21/2-million-astrazeneca-covid-19-vaccines-arrive-in-ph-through-covax">2 million AstraZeneca COVID-19 vaccines arrive in PH through COVAX</a></li>	<li><a href="https://news.abs-cbn.com/news/04/28/21/philippines-asking-us-israel-for-unused-astrazeneca-vaccines-galvez">Philippines asking US, Israel for unused AstraZeneca vaccines: Galvez</a></li></ul><div><br/><strong>RELATED VIDEO:</strong></div><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1638320" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div><div><em>More details to follow.</em></div>

<p>Britain's competition regulator said on Tuesday it was probing if AstraZeneca's $39 billion takeover of US drugmaker Alexion could reduce competition for products and services in the country or elsewhere.</p>

Britain's competition regulator said on Tuesday it was probing if AstraZeneca's $39 billion takeover of US drugmaker Alexion could reduce competition for products and services in the country or elsewhere.